US Medical Affairs, Lung Cancer Evidence & Strategy Intern
About The Position
This is a 12-week internship based at the company’s Gaithersburg, Maryland site, running from May 24, 2027 to August 13, 2027. The intern will support U.S. Medical Affairs by reviewing and organizing the evolving lung cancer evidence landscape, with particular focus on EGFR-mutated non-small cell lung cancer, emerging therapies, clinical trials, biomarkers, and other relevant scientific developments. The role involves analyzing and synthesizing clinical trial results, scientific literature, and major oncology congress updates to identify treatment trends, evidence gaps, and scientific questions that may affect future lung cancer management. The intern will develop and maintain an integrated evidence and competitive landscape covering key trials, treatment approaches, endpoints, patient populations, upcoming data readouts, and other scientific developments to support Medical Affairs planning. The position requires onsite work in Gaithersburg three days per week. Relocation assistance and CPT support are not provided.
Requirements
- Be a PharmD or Master's-level student studying Pharmaceutical Sciences, Biostatistics, Epidemiology/Public Health, Data Science, Biomedical Sciences, Cancer Biology, Pharmacology, Translational Medicine, or a related life-sciences discipline.
- Have a strong interest in oncology, clinical research, Medical Affairs, or evidence generation.
- Have strong analytical, written, and verbal communication skills, including the ability to summarize complex scientific information clearly.
- Have an expected graduation date after August 2027.
- Have U.S. work authorization at the time of application; CPT support will not be provided.
- Be able to report onsite to the Gaithersburg, Maryland site three days per week.
Nice To Haves
- Ability to critically review and synthesize scientific literature and clinical trial data.
- Experience conducting literature reviews, evidence synthesis, research projects, or scientific presentations.
- Coursework or academic experience in pharmacy, epidemiology, biostatistics, public health, biomedical sciences, clinical research, or a related discipline.
- Exposure to clinical trial design, interpretation of efficacy and safety endpoints, or basic statistical concepts.
- Ability to work independently on a defined project while collaborating effectively with cross-functional stakeholders.
- Proficiency with Microsoft Excel and PowerPoint.
- Experience with data visualization or analytical tools such as Power BI, R, Python, or similar platforms.
Responsibilities
- Conduct structured reviews of the evolving lung cancer evidence landscape, focusing on EGFR-mutated non-small cell lung cancer, emerging therapies, clinical trials, biomarkers, and relevant scientific developments.
- Analyze and synthesize clinical trial results, scientific literature, and major oncology congress updates.
- Identify emerging treatment trends, evidence gaps, and scientific questions that may affect future lung cancer management.
- Develop and maintain an integrated evidence and competitive landscape of key clinical trials, treatment approaches, relevant endpoints and patient populations, upcoming data readouts, and other scientific developments.
- Support U.S. Medical Affairs planning.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
What This Job Offers
Job Type
Full-time
Career Level
Intern
